
Tech Mahindra CEO on India's AI Capabilities
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
9 minutes ago
- Yahoo
Tempus AI Raises Outlook, CEO Cites Faster-Than-Expected Growth And Improved Margins
Tempus AI Inc. (NASDAQ:TEM) reported second-quarter financial results Friday. The AI-focused precision medicine and patient care company reported a second-quarter adjusted loss of 22 cents per share, beating analyst estimates for a loss of 24 cents per share. Tempus AI reported quarterly revenue of $314.64 million, beating the consensus estimates of $296.85 million. Revenue increased 89.6% year-over-year. Genomics contributed $241.8 million in revenue in the quarter, growing 115.3% year over testing (Tempus genomics) delivered $133.2 million of revenue, up 32.9%, with approximately 26% volume growth versus 20% last quarter. Hereditary testing sales (Ambry genetics) reached $97.3 million, up 33.6% year-over-year on a pro forma basis with approximately 32% volume growth. Revenue from Data and services totaled $72.8 million, delivering 35.7% growth versus the second quarter of 2024, led by Insights (data licensing), which grew 40.7% year-over-year. Adjusted EBITDA of ($5.6 million) in the second quarter of 2025 compared to ($31.2 million) in the second quarter of 2024, an improvement of $25.6 million year-over-year. View more earnings on TEM 'The business is performing well with revenues and margins growing faster than expected, contributing to our continued improvement in adjusted EBITDA on a year-over-year basis,' said Eric Lefkofsky, Founder and CEO of Tempus. 'We saw significant re-acceleration of our clinical volumes, which grew 30% in the quarter, as we delivered more than 212,000 NGS tests,' Lefkofsky said in a statement on Friday. Database Update Through more than 4,500 integrations, Tempus said it connected to more than 40 million clinical patient records, with around 9 million de-identified and ingested, spanning approximately 1.1 billion healthcare documents, a significant percentage of which are connected to the around 4 million samples the company has sequenced. As a result, the company's database stands at over 350 petabytes of connected clinical and molecular data. Tempus AI ended the quarter with $293.0 million in cash and marketable securities, an improvement of around $70 million over last quarter. Outlook Tempus AI increased its guidance and expects a full year of 2025 revenue of approximately $1.26 billion for the consolidated business, representing approximately 82% annual growth, compared to the consensus of $1.25 billion. Earlier, the company expected revenue between $1.24 billion and $1.25 billion for its consolidated Tempus and Ambry Genetics business. The company reaffirms full-year 2025 adjusted EBITDA of $5 million, an improvement of approximately $110 million over 2024. Tempus AI received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its ejection fraction software in July. Tempus said the FDA granted it 510(k) clearance for its Tempus ECG-Low EF software, which uses AI to identify patients with a potential left ventricular ejection fraction. Price Action: Tempus AI shares were up 5.79% after hours, trading at $55.21 at the time of publication on Tuesday. Read Next:Photo by Piotr Swat via Shutterstock Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? This article Tempus AI Raises Outlook, CEO Cites Faster-Than-Expected Growth And Improved Margins originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved.
Yahoo
9 minutes ago
- Yahoo
ATA Creativity Global (AACG) Q2 2025 Earnings Call Highlights: Revenue Growth Amid Enrollment ...
Release Date: August 07, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points ATA Creativity Global (NASDAQ:AACG) reported a year-over-year increase in net revenues and gross profits for the second quarter of 2025. The company saw a significant 54.2% growth in revenues from research-based learning, overseas study counseling, and other educational services. Operating expenses decreased by 9.4% compared to the second quarter of 2024, contributing to improved financial performance. AACG's project-based programs saw a 25.7% increase in credit hours delivered, highlighting the popularity and flexibility of these offerings. The company successfully expanded its international partnership network, enhancing its global reach and student opportunities. Negative Points Total student enrollment decreased by 3.1% in the second quarter of 2025 compared to the prior year period. Despite revenue growth, AACG reported a net loss of RMB10.8 million for the second quarter of 2025. The decrease in student enrollment was attributed to normalized demand following a rebound in previous years. Time-based programs saw a decrease in credit hours delivered, as more students opted for project-based tracks. The company faces intensified competition in the creative arts education market, which could impact future growth. Q & A Highlights Warning! GuruFocus has detected 6 Warning Signs with AACG. Q: Can you provide an overview of the financial performance for the second quarter of 2025? A: ATA Creativity Global CFO, Mr. Roba Sima, reported a year-over-year increase in net revenues and gross profits for the second quarter of 2025. Net revenues were RMB 55.9 million, an 8% increase from the previous year, primarily driven by overseas study counseling services and other educational services. Gross profit increased by 10.2% to RMB 28.3 million, with improved gross margins of 50.6%. Operating expenses decreased by 9.4%, leading to a narrowed net loss of RMB 10.8 million compared to RMB 16.8 million in the prior year. Q: What were the key drivers of revenue growth during this period? A: The primary drivers of revenue growth were the increased contributions from research-based learning, overseas study counseling, and other educational services. These areas saw a 54.2% growth compared to the previous year, with significant revenue growth in overseas study counseling services due to more services delivered and a high number of student admissions to prestigious institutions. Q: How did student enrollment trends impact the company's performance? A: Total student enrollment for the second quarter of 2025 was 1,050, a decrease of 3.1% from the prior year. This decline was attributed to normalized demand compared to the rebound in 2023 and the first half of 2024. Despite this, project-based programs saw a 25.7% increase in credit hours delivered, indicating a shift in student preference towards more flexible and customizable learning tracks. Q: What are the expectations for the full year 2025? A: The company expects total net revenues for the full year 2025 to be between RMB 276 million and RMB 281 million, representing a year-over-year increase of 3% to 5%. Portfolio training is anticipated to remain the main revenue pillar, with increased contributions from other business lines as the company continues to enhance its offerings and introduce new programs. Q: What strategic initiatives are being implemented to support long-term growth? A: ATA Creativity Global is focusing on organic expansion across all business lines, enhancing cost discipline, and improving efficiency to boost bottom-line results. The company is expanding its international partnership network and introducing new research-based learning projects and travel programs to diversify offerings and enhance student experiences. Additionally, cost-conscious methods such as maintaining a lean sales team and utilizing online marketing are being implemented to reduce operating expenses. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


Skift
12 minutes ago
- Skift
Oberoi Bets on Asset-Light Model With 25 New Hotels in the Pipeline
The Oberoi Group is certainly taking advantage of the upward momentum of the hotel industry in India, but with the Oberoi touch - premium services call for premium prices and EIH Limited is not shying away from charging for it. Indian luxury hotel chain The Oberoi Group plans to add 25 new hotels to its portfolio by 2030, the company's Chief Financial Officer Vineet Kapur said during an earnings call Friday. The expansion will add over 2,000 rooms. The group's next phase of growth will follow an asset-light model. Of the 25 upcoming properties only eight will be owned by parent company EIH Limited, while the remaining 17 will be managed by the group under management contracts. This marks a major shift from the group's current approach. In Oberoi's current portfolio of 29 hotels, only seven are managed by the group. The other 21 are either owned by EIH Limited or involve some level of ownership interest. The group had first announced